투시 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the fluoroscopy market size is expected to grow from USD 9.28 billion in 2025 to USD 9.70 billion in 2026 and is forecast to reach USD 12.07 billion by 2031 at 4.49% CAGR over 2026-2031.

This report is Segmented by Type (Device [Fixed Fluoroscopes and Mobile Fluoroscopes], Consumables & Accessories, and Software & Services), Application (Orthopedic, Cardiovascular, and More), End User (Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). Market Forecasts are Provided in Terms of Value (USD).

Global Fluoroscopy Market Trends and Insights

Rising Prevalence of Chronic Diseases Such as Cardiovascular and Orthopedic Conditions

Ischemic heart disease and osteoarthritis together affect a very large global population, sustaining steady demand for catheter-based cardiovascular interventions and fluoroscopy-guided joint injections within hospitals and ambulatory surgical centers. Percutaneous coronary intervention volumes in the United States remain high, and case complexity continues to increase as physicians address chronic total occlusions and bifurcation lesions that require biplane fluoroscopy and rotational angiography in advanced labs. Orthopedic trauma procedures for older patients, including hip fracture fixation, depend on intraoperative C-arm imaging for guide-wire placement and fracture alignment checks, which sustains high utilization across Level I trauma centers. Rising diabetes prevalence, at more than 500 million adults globally, accelerates peripheral artery disease caseloads, increasing the frequency of below-the-knee angioplasty under fluoroscopic guidance. Regulatory frameworks such as the FDA 510(k) pathway and EU MDR certification establish dose-output and image-quality thresholds, which push manufacturers toward cesium-iodide flat-panel detectors and improved image processing in the fluoroscopy market.

Growing Demand for Minimally Invasive and Image-Guided Surgeries

Surgeons performing endovascular aneurysm repair, kyphoplasty, and transforaminal epidural steroid injections rely on real-time fluoroscopic visualization to navigate devices through vascular or spinal anatomy, which keeps the fluoroscopy market central to interventional workflows. Reimbursement models in the United States and parts of Europe encourage outpatient settings when clinically appropriate, which supports ambulatory surgical centers as they acquire mobile C-arms with motorized positioning and touchless controls that reduce setup time and room turnover. Cone-beam CT on advanced C-arms now enables intraoperative cross-sectional confirmation for spine and orthopedic procedures, which reduces transfers to CT suites and supports same-day discharge pathways. Interventional radiologists optimize dose with pulsed fluoroscopy at lower frame rates, which maintains procedural success and helps meet departmental dose-management goals. Hybrid operating rooms increasingly adopt ceiling-mounted fluoroscopy systems that coordinate with anesthesia and echocardiography equipment through robotic articulation to manage complex structural heart procedures in a compact footprint.

High Cost of Fluoroscopy Equipment and Maintenance

Premium fixed systems with advanced features such as cone-beam CT, flat-panel detectors, and robotic positioning carry high list prices that exceed capital budgets in many public hospitals across resource-constrained regions, which complicates tender cycles and slows replacements in the fluoroscopy market. Maintenance contracts that include detector calibration, X-ray tube coverage, and software updates add recurring costs that some facilities defer, which contributes to unplanned downtime and delays in interventional schedules. Mobile C-arms vary widely in capability and price, which affects adoption among ambulatory surgical centers that operate on thin margins and must prioritize rapid return on investment. Refurbished systems lower acquisition costs, but limited warranties and fewer dose-optimization features can complicate compliance with updated safety standards that many regulators and hospital accreditors now reference. Leasing and pay-per-use models improve access but depend on reliable power, PACS connectivity, and trained service teams, which remain uneven in rural regions and can lower utilization for the fluoroscopy market in emerging economies.

Other drivers and restraints analyzed in the detailed report include:

1. Advancements in Fluoroscopy Technology Including Digital Flat-Panel Systems and Dose-Reduction Methods
2. Increasing Aging Population Requiring Diagnostic and Interventional Procedures
3. Radiation Exposure Risks for Patients and Clinicians

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Device hardware held a 60.78% share of the fluoroscopy market in 2025, led by fixed fluoroscopy suites and mobile C-arms installed in interventional radiology, cardiology, and operating rooms. Fixed systems dominate complex procedures where biplane imaging and large flat-panel detectors are preferred, while mobile systems support orthopedic trauma and pain management where portability and smaller footprint matter in the fluoroscopy market. Mini C-arms priced well below full-size units continue to find traction in ambulatory centers for extremity imaging, supporting the outpatient migration. Consumables and accessories are projected to expand at 6.43% as facilities standardize single-use sterile drapes, radiation-shielding curtains, and contrast injectors to meet infection control and accreditation requirements. Dose-management platforms and advanced visualization software often launch as subscriptions, which expands the revenue pool beyond replacement cycles and strengthens service-led differentiation for the fluoroscopy market.

Consumables and accessories are expanding at a 6.43% CAGR through 2031, and the fluoroscopy market size for this category benefits from infection-prevention policies and standardized kits aligned to ASC workflows. Procurement teams evaluate ISO 13485-certified suppliers for disposable kits and device accessories, which reduces supply risk and aligns with hospital quality systems. On the device side, networked platforms must address cybersecurity guidance from the FDA, and many buyers now include cybersecurity questionnaires and software bill of materials in tenders for the fluoroscopy industry. As providers integrate more third-party analytics and navigation tools, interoperability and vendor-neutral service models are becoming differentiators in the fluoroscopy market.

Complete Report Scope:

• By Type
  • Device
    • Fixed Fluoroscopes
    • Mobile Fluoroscopes (Full-size, Mini C-arms)
  • Consumables & Accessories
  • Software & Services
• By Application
  • Orthopedic
  • Cardiovascular
  • Pain Management & Trauma
  • Neurology
  • Gastrointestinal
  • Urology
  • Other Applications
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Others
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held a 43.90% share of the fluoroscopy market in 2025, reflecting Medicare coverage for image-guided spinal procedures, a large installed base of fixed systems, and sustained procedure volumes in interventional cardiology and pain management. The United States drives most regional demand as hospital capital budgets normalize and hybrid OR construction picks up across cardiovascular and neuro service lines, which favors premium platforms and integrated software within the fluoroscopy market. Canada continues to upgrade analog systems installed before 2015 to meet dose-reduction guidance under Safety Code 35, and Mexico's private sector expands capacity with refurbished mobile C-arms to support orthopedic trauma and medical tourism. FDA 510(k) clearances shape time-to-market for new models, and providers maintain consistent reliance on dose reporting and ACR-specified safety practices.

Europe is the second-largest region, supported by replacement cycles at the 10-year mark and heightened regulatory requirements under EU MDR that push vendors to refresh technical documentation and clinical evaluation for legacy systems in the fluoroscopy market. Germany, the United Kingdom, France, Italy, and Spain account for the majority of demand, with Germany's hospital landscape procuring premium systems featuring cone-beam CT and robotic positioning for high-volume interventional suites. The United Kingdom's NHS consolidates interventional radiology into regional hubs, which increases throughput in centers equipped with 3D navigation and advanced dose management. Rest of Europe adopts mobile C-arms in outpatient settings where orthopedics and pain procedures continue to grow, while the EU Basic Safety Standards directive drives standardized dose audits and formal optimization protocols across providers.

Asia-Pacific is the fastest-growing region at a 5.34% CAGR through 2031, propelled by public investment programs that emphasize hospital capacity and equipment localization, which increases both entry-level and premium demand in the fluoroscopy market. China's domestic manufacturers expand share in mobile C-arms through cost positioning, while multinationals maintain a lead in high-end fixed systems for tier-1 hospitals. Japan's aging demographics sustain vertebroplasty and interventional cardiology volumes despite lengthening replacement cycles, and India's private hospital chains expand cath labs in tier-2 cities with vendor financing that supports deferred payments. Australia upgrades platforms to align with national dose reference levels and South Korea reimburses image-guided spine procedures, which secures ASC adoption of mini C-arms. In the Middle East and Africa, the Gulf states build specialty hospitals with hybrid rooms and 3D navigation, while South Africa's private sector replaces older analog units to align with radiation safety rules. In South America, Brazil's public system deploys mobile C-arms to trauma centers, Argentina's private clinics import systems under duty exemptions, and regional public hospitals procure entry-level platforms under PAHO guidance, which supports steady fluoroscopy market activity as workforce and supply-chain constraints improve.

1. Allengers Medical Systems
2. Canon
3. Carestream Health
4. Eurocolumbus (Stephanix Group)
5. FUJIFILM
6. Fujifilm Healthcare (Mobile C-arms & RF)
7. GE Healthcare
8. Genoray Co. Ltd.
9. Hologic
10. Koninklijke Philips
11. Lepu Medical
12. Nanjing Perlove Medical
13. Omega Medical Imaging
14. Orthoscan
15. Siemens Healthineers
16. Shimadzu
17. Skanray Technologies
18. SternMed
19. Trivitron Healthcare
20. United Imaging Healthcare

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence of Chronic Diseases Such as Cardiovascular and Orthopedic Conditions
  • 4.2.2 Growing Demand for Minimally Invasive and Image-Guided Surgeries
  • 4.2.3 Advancements in Fluoroscopy Technology Including Digital Flat-Panel Systems And Dose?Reduction Methods
  • 4.2.4 Increasing Aging Population Requiring Diagnostic and Interventional Procedures
  • 4.2.5 Expansion of Healthcare Infrastructure In Emerging Economies
  • 4.2.6 Integration with Other Imaging Modalities and Improved Visualization Capabilities
• 4.3 Market Restraints
  • 4.3.1 High Cost of Fluoroscopy Equipment and Maintenance
  • 4.3.2 Radiation Exposure Risks for Patients And Clinicians
  • 4.3.3 Shortage of Skilled Professionals Trained in Advanced Fluoroscopy Systems
  • 4.3.4 Stringent Regulatory Approvals and Safety Compliance Requirements
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, in USD)

• 5.1 By Type
  • 5.1.1 Device
    • 5.1.1.1 Fixed Fluoroscopes
    • 5.1.1.2 Mobile Fluoroscopes (Full-size, Mini C-arms)
  • 5.1.2 Consumables & Accessories
  • 5.1.3 Software & Services
• 5.2 By Application
  • 5.2.1 Orthopedic
  • 5.2.2 Cardiovascular
  • 5.2.3 Pain Management & Trauma
  • 5.2.4 Neurology
  • 5.2.5 Gastrointestinal
  • 5.2.6 Urology
  • 5.2.7 Other Applications
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Diagnostic Imaging Centers
  • 5.3.4 Others
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Allengers Medical Systems
  • 6.3.2 Canon Medical Systems
  • 6.3.3 Carestream Health
  • 6.3.4 Eurocolumbus (Stephanix Group)
  • 6.3.5 FUJIFILM Healthcare
  • 6.3.6 Fujifilm Healthcare (Mobile C-arms & RF)
  • 6.3.7 GE HealthCare
  • 6.3.8 Genoray Co. Ltd.
  • 6.3.9 Hologic Inc.
  • 6.3.10 Koninklijke Philips N.V.
  • 6.3.11 Lepu Medical Technology
  • 6.3.12 Nanjing Perlove Medical
  • 6.3.13 Omega Medical Imaging
  • 6.3.14 Orthoscan Inc.
  • 6.3.15 Siemens Healthineers
  • 6.3.16 Shimadzu Corporation
  • 6.3.17 Skanray Technologies
  • 6.3.18 SternMed GmbH
  • 6.3.19 Trivitron Healthcare
  • 6.3.20 United Imaging Healthcare

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment